Hubert James Ford III MD
Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Associate Professor of Medicine, Director Pulmonary Hypertension Program, University of North Carolina at Chapel Hill
Join to View Full Profile
130 Mason Farm RdCb 7020Chapel Hill, NC 27599
Phone+1 919-966-2531
Dr. Ford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2004 - 2026
FL State Medical License 2004 - 2006
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Tadalafil for Sarcoidosis Associated Pulmonary Hypertension Start of enrollment: 2011 Mar 01
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01 - 5 citationsPrediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.Dan Grinnan, Le Kang, Christine DeWilde, David Badesch, Raymond Benza
Pulmonary Circulation. 2022-07-01 - 13 citationsHealth disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension As...Hilary M. DuBrock, Charles D. Burger, Sonja Bartolome, Jeremy Feldman, D. Dunbar Ivy
Pulmonary Circulation. 2021-06-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
